Lakewood-Amedex Biotherapeutics Announces Positive Antimicrobial Resistance Data for Lead Candidate Targeting Infected Diabetic Foot Ulcers

Go back to Lakewood-Amedex Biotherapeutics Announces Positive Antimicrobial Resistance Data for Lead Candidate Targeting Infected Diabetic Foot Ulcers
(NASDAQ: LABT) Delayed: 3.06 -0.35 (10.26%)
Previous Close $3.41    52 Week High
Open $3.55    52 Week Low
Day High $3.55    P/E N/A 
Day Low $2.77    EPS
Volume 2,042,986